Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1963 2
1968 2
1969 6
1970 3
1971 2
1972 3
1973 5
1974 1
1975 1
1976 3
1977 3
1979 4
1980 3
1981 2
1982 6
1983 11
1984 9
1985 12
1986 16
1987 6
1988 20
1989 18
1990 22
1991 17
1992 14
1993 15
1994 16
1995 10
1996 16
1997 9
1998 12
1999 10
2000 13
2001 10
2002 5
2003 9
2004 12
2005 8
2006 11
2007 8
2008 8
2009 10
2010 11
2011 15
2012 15
2013 23
2014 21
2015 15
2016 7
2017 7
2018 8
2019 17
2020 21
2021 16
2022 9
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Results by year

Filters applied: . Clear all
Page 1
Saying Goodbye.
Gutmann L. Gutmann L. Neurology. 2024 Jun;102(11):e209446. doi: 10.1212/WNL.0000000000209446. Epub 2024 May 8. Neurology. 2024. PMID: 38718315 No abstract available.
The Auxiliary to the American Academy of Neurology.
Badihian N, Christy AL, Boes CJ, Gutmann L, Coon EA. Badihian N, et al. Among authors: gutmann l. Neurology. 2024 Mar 12;102(5):e209142. doi: 10.1212/WNL.0000000000209142. Epub 2024 Feb 6. Neurology. 2024. PMID: 38320220 Review.
Veni, Vidi, Scribivi: I Came, I Saw, I Wrote.
Acosta LMY, Gutmann L, Moawad H, Wynn ML. Acosta LMY, et al. Among authors: gutmann l. Neurology. 2024 Jan 9;102(1):e208017. doi: 10.1212/WNL.0000000000208017. Epub 2023 Dec 14. Neurology. 2024. PMID: 38165386
Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke.
Chalos V, Venema E, Mulder MJHL, Roozenbeek B, Steyerberg EW, Wermer MJH, Lycklama À Nijeholt GJ, van der Worp HB, Goyal M, Campbell BCV, Muir KW, Guillemin F, Bracard S, White P, Dávalos A, Jovin TG, Hill MD, Mitchell PJ, Demchuk AM, Saver JL, van der Lugt A, Brown S, Dippel DWJ, Lingsma HF; HERMES CollaboratorsMR CLEAN Registry Investigators. Chalos V, et al. JAMA Neurol. 2023 Jul 31;80(9):940-8. doi: 10.1001/jamaneurol.2023.2392. Online ahead of print. JAMA Neurol. 2023. PMID: 37523199
Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
Rosenkranz SC, Gutmann L, Has Silemek AC, Dorr M, Häußler V, Lüpke M, Mönch A, Reinhardt S, Kuhle J, Tilsley P, Heesen C, Friese MA, Brandt A, Paul F, Zimmermann H, Stellmann JP. Rosenkranz SC, et al. Among authors: gutmann l. J Neurol Neurosurg Psychiatry. 2023 Nov;94(11):924-933. doi: 10.1136/jnnp-2023-331183. Epub 2023 Jul 11. J Neurol Neurosurg Psychiatry. 2023. PMID: 37433662
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.
Quintana M, Saville BR, Vestrucci M, Detry MA, Chibnik L, Shefner J, Berry JD, Chase M, Andrews J, Sherman AV, Yu H, Drake K, Cudkowicz M, Paganoni S, Macklin EA; HEALEY ALS Platform Trial Study Group. Quintana M, et al. Ann Neurol. 2023 Sep;94(3):547-560. doi: 10.1002/ana.26714. Epub 2023 Jun 22. Ann Neurol. 2023. PMID: 37245090
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.
Al-Hakem H, Doets AY, Stino AM, Zivkovic SA, Andersen H, Willison HJ, Cornblath DR, Gorson KC, Islam Z, Mohammad QD, Sindrup SH, Kusunoki S, Davidson A, Casasnovas C, Bateman K, Miller JAL, van den Berg B, Verboon C, Roodbol J, Leonhard SE, Arends S, Luijten LWG, Benedetti L, Kuwabara S, Van den Bergh P, Monges S, Marfia GA, Shahrizaila N, Galassi G, Pereon Y, Bürmann J, Kuitwaard K, Kleyweg RP, Marchesoni C, Sedano Tous MJ, Querol L, Martín-Aguilar L, Wang Y, Nobile-Orazio E, Rinaldi S, Schenone A, Pardo J, Vermeij FH, Waheed W, Lehmann HC, Granit V, Stein B, Cavaletti G, Gutiérrez-Gutiérrez G, Barroso FA, Visser LH, Katzberg HD, Dardiotis E, Attarian S, van der Kooi AJ, Eftimov F, Wirtz PW, Samijn JPA, Gilhuis HJ, Hadden RDM, Holt JKL, Sheikh KA, Kolb N, Karafiath S, Vytopil M, Antonini G, Feasby TE, Faber C, Kramers H, Busby M, Roberts RC, Silvestri NJ, Fazio R, van Dijk GW, Garssen MPJ, Verschuuren J, Harbo T, Jacobs BC; IGOS Consortium. Al-Hakem H, et al. Neurology. 2023 Jun 6;100(23):e2386-e2397. doi: 10.1212/WNL.0000000000207282. Epub 2023 Apr 19. Neurology. 2023. PMID: 37076309
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.
Kishnani PS, Diaz-Manera J, Toscano A, Clemens PR, Ladha S, Berger KI, Kushlaf H, Straub V, Carvalho G, Mozaffar T, Roberts M, Attarian S, Chien YH, Choi YC, Day JW, Erdem-Ozdamar S, Illarioshkin S, Goker-Alpan O, Kostera-Pruszczyk A, van der Ploeg AT, An Haack K, Huynh-Ba O, Tammireddy S, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Kishnani PS, et al. JAMA Neurol. 2023 Jun 1;80(6):558-567. doi: 10.1001/jamaneurol.2023.0552. JAMA Neurol. 2023. PMID: 37036722 Free PMC article. Clinical Trial.
Together.
Gutmann L. Gutmann L. Neurology. 2023 Apr 25;100(17):826-827. doi: 10.1212/WNL.0000000000206761. Epub 2022 Dec 22. Neurology. 2023. PMID: 36549912 Free PMC article. No abstract available.
537 results